Drugs / YK0901 cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05933668 | Jul 2023 → Jul 2024 overdue | neoplasm | Peking University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YK0901 cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05933668 ↗ |
| Modality | Cell therapy | “YK0901 TCR-T cell” NCT05933668 ↗ |